Jfl Life Sciences Limited

Jfl Life Sciences Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN L24230GJ2010PLC060417 Incorporated 25 April 2010 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Listed Public Limited Company pharma
Data last updated
Market Cap
₹34.15 Cr
JFLLIFE-SM · NSE
Share Price
₹10.35
0.00% today
Revenue
₹131 Cr
FY 2025-26 · +62.0% YoY
EBITDA
₹11.71 Cr
Margin 8.9%
Net Profit
₹6.39 Cr
FY 2025-26 · +54.0% YoY
P/E (TTM)
4.9x
P/B 0.7x

About Jfl Life Sciences Limited

Data last updated: 28 September 2026

Jfl Life Sciences Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 25 April 2010, the company has been in operation for over 16 years.

Registered with ROC Ahmedabad under CIN L24230GJ2010PLC060417. Listed.

Capital: an authorised share capital of ₹67.5 Cr and a paid-up capital of ₹33 Cr. Formerly known as Jfl Life Sciences Private Limited. It is led by directors including Bhavna Basantbhai Shah and Manishkumar Jasvantlal Patel.

Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: Ahmedabad, Gujarat.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹131.38 Cr, a growth of 60.14% compared to the previous year.

The company is associated with 1 brand - Jfl Life Sciences. As per MCA filings, the company has open charges of ₹24.22 Cr and satisfied charges of ₹16.19 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jfllifesciences.com.

Company Details of Jfl Life Sciences Limited
CIN L24230GJ2010PLC060417
Registration Number 060417
Incorporation Date 25 April 2010
ROC Ahmedabad
Listing Status Listed
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Smiral Ashwinkumar Patel Managing Director Tejal Smiral Patel Whole-Time Director Bhavna Basantbhai Shah Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    jfllifesciences.com
  • Social Media
    Locked
  • Registered Address
    309 Satyam Mall Opp. Saman Complex Nr. Vishweshwar Mahadev Mandir Settelit, E, Ahmedabad, Gujarat, India – 380015
  • Industry
    Pharma, Drug Formulation & Development
Company report
Jfl Life Sciences Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Jfl Life Sciences Limited report

Financials, compliance, directors, charges, ownership and filings for Jfl Life Sciences Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Jfl Life Sciences Limited

Jfl Life Sciences Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24230GJ2010PLC060417, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24230GJ2010PLC060417 Current
U24230GJ2010PLC060417 Previous
U24230GJ2010PTC060417 Previous

Associated Brands with Jfl Life Sciences Limited

Jfl Life Sciences Limited operates one associated brand: JFL LIFE SCIENCES. These brands represent Jfl Life Sciences Limited's diversified market presence and brand portfolio.

Brand Description Website
JFL LIFE SCIENCES
General tablets, capsules, and dry powder injections are manufactured. jfllifesciences.com

Business Activity of Jfl Life Sciences Limited

Jfl Life Sciences Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Jfl Life Sciences Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Jfl Life Sciences Limited

Jfl Life Sciences Limited is audited by Doshi Doshi & Co for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Doshi Doshi & Co Locked Locked Locked
Premium access

Complete auditor history for Jfl Life Sciences Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Jfl Life Sciences Limited

Jfl Life Sciences Limited is currently managed by 6 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Bhavna Basantbhai Shah
Also directs: Jfl Life Sciences Limited, City Crops Agro Limited
Director 10 Feb 2022 4 Years 7 Months Current
Manishkumar Jasvantlal Patel
Also directs: Jfl Life Sciences Limited
Director 10 Feb 2022 4 Years 7 Months Current
Sonu Lalitkumar Jain
Also directs: Jfl Life Sciences Limited, Achyut Healthcare Limited
Director 18 Jan 2022 4 Years 8 Months Current
Smiral Ashwinkumar Patel
Also directs: Jfl Life Sciences Limited, Jfl Healthcare Private Limited
Managing Director 18 Jan 2022 4 Years 8 Months Current
Tejal Smiral Patel
Also directs: Jfl Life Sciences Limited, Jfl Healthcare Private Limited
Whole-Time Director 18 Jan 2022 4 Years 8 Months Current
Khyati Bhavya Shah
Also directs: Jfl Life Sciences Limited, Qualitas Consultech Llp, Qualitas Accountants Llp and 5 more
Director 11 Aug 2025 1 Years 1 Months Current
View all directors

Financials of Jfl Life Sciences Limited FY 2025-26 filings available

Jfl Life Sciences Limited reported revenue of ₹131.38 Cr (up 60.14% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹131 Cr
+60.1% YoY
EBITDA
₹11.71 Cr
+43.0% YoY
Profit After Tax
₹6.39 Cr
+54.0% YoY
Net Worth
-
Total Assets
-
Total Debt
-

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue13182.0446.5542.8333.5932.7730.17
Revenue growth+62.0%+75.8%+8.0%+37.8%-7.8%+8.2%-7.1%
EBITDA11.718.194.553.935.362.161.87
EBITDA margin+8.9%+10.0%+9.8%+9.2%+16.0%+6.6%+6.2%
Profit before tax8.596.133.803.723.800.740.50
Net profit6.394.153.302.812.810.540.36
Net profit margin+4.9%+5.1%+7.1%+6.6%+8.4%+1.7%+1.2%
EPS (₹)1.941.263.012.553.5010.918.52
Balance sheet
Total assets-50.1841.3739.5427.1423.7514.75
Net worth-39.4635.5832.2711.296.885.37
Total debt-10.595.697.1815.8516.829.33
Cash & bank-0.060.030.060.190.040.30
Net working capital-38.0827.8631.8118.3615.358.89
Cash flow
Cash from operations-(3.53)8.36(9.07)2.32(5.87)3.21
Cash from investing-(0.01)(6.07)0.87(0.71)(1.64)(2.76)
Cash from financing-3.54(2.31)8.07(1.46)7.25(0.19)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue11.1063.0526.8429.9111.5911.7321.2539.51
Revenue growth (YoY)-4.2%+437.5%+26.3%-24.3%+21.5%-45.9%+279.5%+9997.0%
Other income0.020.040.010.010.000.000.000.00
Total expenses9.0159.5423.4926.999.6510.3619.9037.10
EBITDA2.093.513.352.921.941.371.352.41
EBITDA margin+18.8%+5.6%+12.5%+9.8%+16.7%+11.7%+6.4%+6.1%
Depreciation0.320.270.270.270.260.360.160.24
Interest0.301.030.380.440.240.330.200.27
Profit before tax1.492.252.712.221.440.680.991.90
Tax0.380.590.680.240.690.600.250.44

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 28 Sep 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue11.1063.0526.8429.9111.5911.7321.2539.51
Revenue growth (YoY)-4.2%+437.5%+26.3%-24.3%+21.5%-45.9%+279.5%+9997.0%
Other income0.020.040.010.010.000.000.000.00
Total expenses9.0159.5423.4926.999.6510.3619.9037.10
EBITDA2.093.513.352.921.941.371.352.41
EBITDA margin+18.8%+5.6%+12.5%+9.8%+16.7%+11.7%+6.4%+6.1%
Depreciation0.320.270.270.270.260.360.160.24
Interest0.301.030.380.440.240.330.200.27
Profit before tax1.492.252.712.221.440.680.991.90
Tax0.380.590.680.240.690.600.250.44
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue13182.0446.5542.8333.5932.7730.17
Revenue growth+62.0%+75.8%+8.0%+37.8%-7.8%+8.2%-7.1%
Other income0.070.010.521.640.890.090.03
Total expenses12073.8542.0038.9028.2330.6128.30
Employee cost0.001.012.011.831.430.981.25
EBITDA11.718.194.553.935.362.161.87
EBITDA margin+8.9%+10.0%+9.8%+9.2%+16.0%+6.6%+6.2%
Depreciation1.080.990.440.430.370.280.24
Interest2.111.080.831.422.081.231.16
Profit before tax8.596.133.803.723.800.740.50
Tax2.201.980.500.910.990.200.14
Net profit6.394.153.302.812.810.540.36
Net profit margin+4.9%+5.1%+7.1%+6.6%+8.4%+1.7%+1.2%
EPS (₹)1.941.263.012.553.5010.918.52
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital-33.0011.0011.008.020.500.42
Reserves & surplus-6.4624.5821.273.276.384.95
Shareholders' funds (net worth)-39.4635.5832.2711.296.885.37
Secured loans-10.365.697.1813.5312.915.87
Unsecured loans-0.230.000.002.323.913.46
Total debt-10.595.697.1815.8516.829.33
Total liabilities-50.1841.3739.5427.1423.7514.75
Assets
Gross block-13.8313.088.928.817.796.06
Net block-12.2412.486.807.136.515.05
Capital work in progress-0.000.000.000.000.000.00
Investments-0.000.000.000.000.000.00
Inventories-23.2415.8312.7214.965.743.75
Sundry debtors-34.9525.1522.4819.8011.8112.66
Cash & bank balances-0.060.030.060.190.040.30
Loans & advances-1.252.125.884.352.881.67
Total current assets-59.5043.1341.1439.3020.4718.38
Total current liabilities-21.4215.279.3320.945.129.49
Net working capital-38.0827.8631.8118.3615.358.89
Total assets-50.1841.3739.5427.1423.7514.75
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash-0.030.060.190.040.300.03
Net cash from operating activities-(3.53)8.36(9.07)2.32(5.87)3.21
Net cash from investing activities-(0.01)(6.07)0.87(0.71)(1.64)(2.76)
Net cash from financing activities-3.54(2.31)8.07(1.46)7.25(0.19)
Net change in cash-0.00(0.03)(0.13)0.15(0.26)0.27
Closing cash-0.060.030.060.190.040.30
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+60.1%+76.2%+8.7%+27.5%+2.5%+8.6%-5.1%
EBITDA growth+43.0%+80.0%+15.8%-26.7%+148.2%+15.5%+41.7%
PBT growth+40.1%+61.3%+2.2%-2.1%+413.5%+48.0%+19.1%
Net income growth+54.0%+25.8%+17.4%0.0%+420.4%+50.0%+20.0%
Revenue CAGR (3Y)+45.3%+34.7%+12.4%+12.4%+1.9%--
EBITDA CAGR (3Y)+43.9%+15.2%+28.2%+28.1%+59.5%--
Profitability & leverage
Net income margin+4.9%+5.1%+7.1%+6.6%+8.4%+1.7%+1.2%
Return on capital employed-+15.8%+11.4%+15.4%+23.1%+10.2%+11.8%
Return on net worth-+11.1%+9.8%+12.9%+30.9%+8.8%+6.9%
Debt / equity-0.220.190.531.802.131.71
Long-term debt / equity-0.020.030.220.910.780.41
Interest cover19.8515.0020.1940.5741.6865.4371.17
Efficiency & per share
Fixed asset turnover-6.104.234.834.054.736.48
Inventory turnover-4.203.263.093.256.9111.05
Debtors turnover-2.731.952.032.132.682.70
EPS (₹)1.941.263.012.553.5010.918.52
Dividend per share (₹)0.000.000.250.000.000.000.00
Book value per share (₹)0.0011.9632.3529.3414.08138.28127.11
Want more history and ratios?
You're viewing the latest exchange-filed financials for Jfl Life Sciences Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Jfl Life Sciences Limited

As per the shareholding pattern for the quarter ended Jun 2026, promoters hold 67.50%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 32.50% of Jfl Life Sciences Limited.

Promoters: 67.50%Retail & Others: 32.50%
Jun 2026
QUARTER
67.50% Promoters
32.50% Retail & Others
Promoter holding - history
Now 67.50% · Jun 2026High 67.50% · Sep 2025Low 67.50% · Sep 2025
66%66.8%67.5%68.3%69%Sep 2025Dec 2025Mar 2026Jun 2026Sep 2025: 67.50%Dec 2025: 67.50%Mar 2026: 67.50%Jun 2026: 67.50%67.50%67.50%
Shareholding trend - last 6 quarters
Jun 2026Mar 2026Dec 2025Sep 2025
Promoters67.50%67.50%67.50%67.50%
Public32.50%32.50%32.50%32.50%

Charges & Borrowings of Jfl Life Sciences Limited

Open charges
₹24.22 Cr
Satisfied charges
₹16.19 Cr
Breakdown by lending institutions
Others₹24.22 Cr
Latest charge details
DateLenderAmountStatus
05 Jan 2026 Others ₹92.8 Lakh Open
07 Nov 2025 Others ₹6.5 Cr Open
08 Apr 2024 Others ₹16.79 Cr Open
28 Dec 2020 Others ₹3.74 Cr Satisfied
08 Oct 2020 Sidbi ₹3 Cr Satisfied

Total charge records: 8 View all charges

Employees and EPFO Compliance at Jfl Life Sciences Limited

Jfl Life Sciences Limited has a workforce of 0 employees as of Feb 28, 2025.

Active EPFO establishments
1
Premium access

Employee and EPFO history for Jfl Life Sciences Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Jfl Life Sciences Limited

Premium access

GST registrations and filing compliance for Jfl Life Sciences Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Jfl Life Sciences Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Jfl Life Sciences Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Jfl Life Sciences Limited

Premium access

MSME payment history for Jfl Life Sciences Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Jfl Life Sciences Limited

Premium access

Corporate group structure for Jfl Life Sciences Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Jfl Life Sciences Limited

Premium access

MCA filings and documents for Jfl Life Sciences Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Jfl Life Sciences Limited

Charges
29 May 2026
A charge with Others of Rs. 16.79 Cr registered on 08 Apr 2024 with Charge ID 100908472 was modified on 29 May 2026.
Charges
05 Jan 2026
A charge with Others amounted to Rs. 0.93 Cr with Charge ID 101224227 was registered on 05 Jan 2026.
Charges
07 Nov 2025
A charge with Others amounted to Rs. 6.50 Cr with Charge ID 101215342 was registered on 07 Nov 2025.
Activity
26 Sep 2025
Jfl Life Sciences Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Directors
11 Aug 2025
Khyati Bhavya Shah was appointed as a Director on 11 Aug 2025 & has been associated with this company since 1 year 1 month.
Directors
01 Apr 2025
Hiral Mahavirsinh Chudasama was appointed as a Company Secretary on 01 Apr 2025 & has been associated with this company since 1 year 5 months.

Frequently Asked Questions about Jfl Life Sciences Limited

Jfl Life Sciences Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 25 April 2010 (16+ years old) and is registered under CIN L24230GJ2010PLC060417.

Jfl Life Sciences Limited reported revenue of ₹131.38 Cr for FY 2025-26 (up 60.14% YoY) based on standalone financials.

The current directors of Jfl Life Sciences Limited are:

The primary industry of Jfl Life Sciences Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes, Jfl Life Sciences Limited is a listed company.

Jfl Life Sciences Limited can be reached at the registered office: 309 Satyam Mall Opp. Saman Complex Nr. Vishweshwar Mahadev Mandir Settelit, E, Ahmedabad, Gujarat, India – 380015, or through the website jfllifesciences.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available